arrow
G

Giuseppe Perrone

Fondazione Policlinico Universitario Campus Bio-Medico
H指数:37
被引数:5,117

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining Method

数字病理调查(VEED)项目中的苏木精-伊红虚拟评估:基于表格的染色方法非劣效性研究结果

2026-06-170
OA
The Italian Portrait of Laboratory Information Systems in Pathology: The Ones We Have and the Ones We Would Like

病理实验室信息系统在意大利的现状与愿景:我们拥有的与我们所期望的

2025-10-310
OAAI
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2-breast cancer after progression on CDK4/6 inhibitor therapy

在HR+/HER2-乳腺癌患者对CDK4/6抑制剂治疗进展后,对来自转移灶的FFPE样本进行ESR1基因检测

2025-05-140
OA
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models
2024-08-280
OAAI
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
2024-01-112
OAAI
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group
2024-01-014
OAAI
Think HER2 different: integrative diagnostic approaches for HER2-low breast cancer

认为HER2不同: HER2-low乳腺癌的综合诊断方法

2023-12-015
OAAI
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

癌症患者的2型糖尿病和免疫检查点阻断的疗效结果

2023-06-0125
OA
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

纤维化非酒精性脂肪性肝炎评分的建立和验证

2023-06-0146
OA
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer (vol 7, 1, 2021)
2023-04-292
OAAI